Nonavalent Vaccine Against HPV Receives Indication for Head and Neck Tumors
Brazil's nonavalent HPV vaccine has been updated to include protection against oropharyngeal cancer and other head and neck tumors associated with the virus.
Anvisa approves new indication for HPV vaccine to prevent oropharyngeal, head, and neck cancers
Brazil's health regulatory agency Anvisa has approved a new indication for the HPV vaccine Gardasil 9 to prevent oropharyngeal, head, and neck cancers in individuals aged 9 to 45.
Head and Neck Cancer: When 'Hoarseness' or 'Swallowing Pain' Are Warning Signs of Danger
Doctors warn that head and neck cancer can develop silently with symptoms that may appear mild, emphasizing the importance of early diagnosis.
Head and Neck Cancer Advances in Women and in the North and Northeast
A recent study published in The Lancet Regional Health – Americas reveals significant changes in head and neck cancer mortality in Brazil over 44 years, highlighting an alarming rise in deaths among women and marginalized communities in the North and Northeast regions.
Artificial saliva helps protect the teeth of head and neck cancer patients
Research indicates that an artificial saliva mouthwash derived from sugarcane protein can aid cancer patients by mitigating the impact of radiation therapy on their salivary glands.